Death-associated protein kinase promoter (DAPK) hypermethylation in uterine cervical cancer and intraepithelial neoplasia in Uyghur nationality women

Chinese Journal of Oncology

Volumn 34, Issue 1, 2012, Pages 31-34

  Niyazi, Mayinuer ^a   Liu, Xiao Wan ^a   Zhu, Kai Chun ^a  

^a PEOPLE S HOSPITAL OF XINJIANG UYGUR AUTONOMOUS REGION   (China)

Author keywords

Death associated protein kinase; Intraepithelial neoplesia; Methylation; Uterine cervical neoplasms; Uyghur nationality

Indexed keywords

DEATH ASSOCIATED PROTEIN KINASE; TUMOR PROMOTER;

ARTICLE; BIOASSAY; CANCER GROWTH; CARCINOGENESIS; CLINICAL ARTICLE; CONTROLLED STUDY; DEATH ASSOCIATED PROTEIN KINASE GENE; FEMALE; GENE; HUMAN; IMMUNOHISTOCHEMISTRY; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; PROTEIN METHYLATION; SQUAMOUS CELL CARCINOMA; UTERINE CERVICITIS; UTERINE CERVIX; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA; UTERINE CERVIX CARCINOMA IN SITU;

ADULT; AGED; APOPTOSIS REGULATORY PROTEINS; CALCIUM-CALMODULIN-DEPENDENT PROTEIN KINASES; CARCINOMA, SQUAMOUS CELL; CERVICAL INTRAEPITHELIAL NEOPLASIA; CHINA; DISEASE PROGRESSION; DNA METHYLATION; FEMALE; HUMANS; MIDDLE AGED; PROMOTER REGIONS, GENETIC; UTERINE CERVICAL NEOPLASMS; UTERINE CERVICITIS;

EID: 84863075944     PISSN: 02533766     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0253-3766.2012.01.007     Document Type: Article

References (8)

1. 2+/ calmodulin-dependent, cytoskeletal-associated protein kinase, with cell death-inducing functions that depend on its catalytic activity. EMBO J, 1997: 998-1008.
2. Bialik S, Kimchi A. DAP-kinase as a target for drug design in cancer and diseases associated with accelerated cell death. Semin Cancer Biol, 2004, 14: 283-294. (Pubitemid 38824589)
3. Reddy AN, Jiang WW, Kim M, et al. Death-associated protein kinase promoter hypermethylation in normal human lymphocytes. Cancer Res, 2003, 63: 7694-7698. (Pubitemid 37466698)
4. Narayan G, Arias-Pulido H, Koul S, et al. Frequent promoter methylation of CDH1, DAPK, RARB, and HIC1 genes in carcinoma of cervix uteri: its relationship to clinical outcome. Mol Cancer, 2003, 2: 24-26.